Vincerx Pharma, Inc. (VINC) Social Stream



Vincerx Pharma, Inc. (VINC): $1.43

0.04 (+2.88%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add VINC to Watchlist
Sign Up

Industry: Biotech


Ranked

of 400

in industry

Vincerx Pharma Inc (VINC) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Vincerx Pharma Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-15 4 $33 $24 $28.6 $3.91 631.46%
2021-12-20 4 $30 $24 $28 $3.91 616.11%
2021-12-23 5 $30 $24 $27.5 $3.91 603.32%
2022-01-17 6 $30 $24 $27.142 $3.91 594.17%
2022-03-29 6 $30.001 $24 $27.143 $3.91 594.19%
2022-03-30 6 $30 $14 $24.285 $3.91 521.1%

The Trend in the Analyst Price Target


VINC's average price target has moved down $8.71 over the prior 36 weeks.

Over the past 51 weeks, VINC's average upside potential has been 171.29%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-10 0 33 33 33.0 19.06 73.14%
2021-08-05 0 33 33 33.0 12.66 160.66%
2021-08-14 0 33 30 31.5 12.96 143.06%
2021-11-01 4 33 24 28.6 14.78 93.5%
2021-12-23 6 30 24 27.5 10.00 175%

VINC Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 6 0 0 0 0 6

The Trend in the Broker Recommendations


Over the past 13 months, VINC's average broker recommendation rating improved by 1.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • VINC has a higher upside potential (average analyst target price relative to current price) than 778.86% of all US stocks.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Vincerx Pharma Inc's variance in analysts' estimates is lower than -78% of them.
  • Vincerx Pharma Inc's number of analysts covering the stock is greater than 527.8% of stocks in the small market cap category.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, Vincerx Pharma Inc's average analyst price target is higher than 500% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Vincerx Pharma Inc are VERU, VERA, and VBIV.

Is VINC a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4186 seconds.